Clinical efficacy of becaplermin (rhPDGF-BB) gel
- 1 August 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 176 (2) , 74S-79S
- https://doi.org/10.1016/s0002-9610(98)00185-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind studyDiabetes Care, 1998
- Costs and duration of care for lower extremity ulcers in patients with diabetesClinical Therapeutics, 1998
- The role of growth factors in the healing of chronic woundsWound Repair and Regeneration, 1997
- The Role of Growth Factors in Wound HealingThe Journal of Trauma: Injury, Infection, and Critical Care, 1996
- A Healed Ulcer: What Now?Diabetic Medicine, 1996
- Long-Term Costs for Foot Ulcers in Diabetic Patients in a Multidisciplinary SettingFoot & Ankle International, 1995
- Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcersJournal of Vascular Surgery, 1995
- Role of Growth Factors in Cutaneous Wound Healing: A ReviewCritical Reviews in Oral Biology & Medicine, 1993
- Diabetic Foot Care: Financial Implications and Practice GuidelinesDiabetes Care, 1992
- Lower-Extremity Amputation in People With Diabetes: Epidemiology and PreventionDiabetes Care, 1989